Macrogenics Stock In The News

MGNX Stock  USD 2.22  0.02  0.91%   
Our overall analysis of MacroGenics' news coverage and content from conventional and social sources shows investors' bearish mood towards MacroGenics. The specific impact of MacroGenics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of MacroGenics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using MacroGenics headlines in addition to utilizing other, more conventional financial analysis modules. Check out MacroGenics Backtesting and MacroGenics Hype Analysis.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

MacroGenics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
https://www.globenewswire.com/news-release/2025/03/06/3038089/0/en/MacroGenics-Announces-Date-of-Fourth-Quarter-and-Full-Year-2024-Financial-Results-Conference-Call.html
 Bullish
Macroaxis News: globenewswire.com
MacroGenics to Participate in Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2025/02/27/3033746/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
Investigation Alert: MacroGenics, Apelli...
https://www.globenewswire.com/news-release/2025/02/06/3022379/0/en/Investigation-Alert-MacroGenics-Apellis-Pharmaceuticals-Teradata-and-Maplebear-Johnson-Fistel-LLP-Encourages-Long-Term-Investors-to-Reach-Out-for-More-Information.html
 Neutral
Yahoo News
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
https://finance.yahoo.com/news/3-biotech-stocks-could-millionaire-160000282.html
 Bullish
Yahoo News
Stocks Pause On Dismal Consumer Confiden...
https://finance.yahoo.com/news/stocks-pause-dismal-consumer-confidence-192826587.html
 Neutral
Yahoo News
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
https://finance.yahoo.com/news/12-most-undervalued-biotech-stocks-180928477.html
 Bullish
Yahoo News
The 3 Most Undervalued Biotech Stocks to Buy in January
https://finance.yahoo.com/news/3-most-undervalued-biotech-stocks-215107832.html
 Bullish
Yahoo News
MacroGenics to Participate in Upcoming Investor Conference
https://finance.yahoo.com/news/macrogenics-participate-upcoming-investor-conference-213000313.html
 Neutral
Yahoo News
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
https://finance.yahoo.com/news/7-undervalued-biotech-stocks-flying-170357195.html
 Bullish
Yahoo News
Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago
https://finance.yahoo.com/news/shareholders-macrogenics-nasdaq-mgnx-red-171642298.html
 Bullish

MacroGenics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide MacroGenics and other traded companies coverage with news coverage. We help investors stay connected with MacroGenics headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on MacroGenics Stock performance. Please note that trading solely based on the MacroGenics hype is not for everyone as timely availability and quick action are needed to avoid losses.
MacroGenics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help MacroGenics investors visualize upcoming and past events in order to time the market based on MacroGenics noise-free hype analysis.
MacroGenics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the MacroGenics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. That information is available publicly through MacroGenics media outlets and privately through word of mouth or via MacroGenics internal channels. However, regardless of the origin, that massive amount of MacroGenics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.

MacroGenics Largest EPS Surprises

Earnings surprises can significantly impact MacroGenics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-05-06
2014-03-31-0.08-0.12-0.0450 
2023-03-15
2022-12-310.10.210.11110 
2020-05-05
2020-03-31-1.02-0.910.1110 
2017-05-03
2017-03-31-0.97-1.08-0.1111 
2017-02-28
2016-12-31-0.89-1.0-0.1112 
2019-05-01
2019-03-31-0.86-0.99-0.1315 
View All Earnings Estimates

MacroGenics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to MacroGenics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
13th of March 2025
Apyx Medical Reports Q4 Loss, Tops Revenue Estimates
at finance.yahoo.com 
Google News at Macroaxis
3rd of March 2025
Macrogenics Stock Hits 52-Week Low at 2.31 Amid Sharp Decline By Investing.com - Investing...
at news.google.com 
news
27th of February 2025
Could This Biopharmaceutical Developer Advance Cancer Treatment
at kalkinemedia.com 
Simply Wall St News at Macroaxis
11th of February 2025
Further weakness as MacroGenics drops 11 percent this week, taking one-year losses to 86
at simplywall.st 
businesswire News
10th of February 2025
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial...
at businesswire.com 
Macroaxis News
7th of February 2025
Acquisition by Jeffrey Peters of 18000 shares of MacroGenics subject to Rule 16b-3
at MacroaxisInsider 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MacroGenics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MacroGenics' short interest history, or implied volatility extrapolated from MacroGenics options trading.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.